Clinical Trials
Elektrofi Announces Collaboration with Thermo Fisher Scientific to Strengthen...
Elektrofi, a biotechnology company focused on drug formulation and delivery innovations, announced a strategic contract manufacturing agreement with Thermo Fisher Scientific to support clinical manufacture...
Press Releases
Government of Telangana and Flanders Investment & Trade to...
In continuation with its focus on strengthening its growing stature in the global Lifesciences ecosystem, the Government of Telangana is taking one more step towards...
Press Releases
School of advanced sciences of VIT-AP signs MoU...
VIT-AP University, Amaravati entered into a Memorandum of Understanding (MoU) on the Data Science program with the State University of New York (SUNY), Binghamton, USA...
Press Releases
BSI Life Sciences and Ledger Run Partner to Streamline...
BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing...
Press Releases
Medical futurist names three trends shaping the future of...
Empowered patients, robots and artificial intelligence are reshaping the pharmaceutical supply chain, says Dr Bertalan Meskó, Director of The Medical Futurist Institute. He will share insights...
Press Releases
Quotient Sciences Expands Formulation Development Capabilities To Further Accelerate...
Quotient Sciences, the drug development and manufacturing accelerator, announced that it has completed an expansion of its early-phase formulation development capabilities for oral dosage forms...
Press Releases
RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000...
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced a significant milestone: they have de-risked over 1000 clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.